cookie

We use cookies to improve your browsing experience. By clicking «Accept all», you agree to the use of cookies.

avatar

Pharmacist Guide ⁦

Pharmacist Guide is an Iraqi medical channel dedicated to explaining pharmacology lectures and Theraputics. Accredited by the CPD Certification Service. YouTube Link: https://www.youtube.com/@PharmacistGuide94 Mohammed Jawad Certified Trainer

Show more
Advertising posts
20 930
Subscribers
+524 hours
+307 days
+17830 days

Data loading in progress...

Subscriber growth rate

Data loading in progress...

آخر تحديث من دليل الأدوية (BNF) #April_2024
Show all...
7
Dear Colleagues, We are delighted to extend an invitation to join Ajanta Pharma Limited as a *Team Leader* - Middle Requirements: 1. Graduated Pharmacist (Male) 2. Efficiently Manage Multiple Activities 3. Proficient in English Communication 4. Competent in Office Applications 5. Have a good people management skills and efficient problem techniques. 6. Willingness to Travel frequently. 7. Based Hilla or Najaf. If you meet these qualifications and are excited to contribute to our dynamic team, please submit your resume to [email protected] Best Regards,
Show all...
4
5 criteria have to be fulfilled before starting SGLT2 inhibitors during an acute Heart failure admission From "Tips and Tricks in Cardiology" Book Volume III
Show all...
7👍 2
1
🔴 SGL2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease ✅SGLT2i use was associated with a lower risk for dialysis, cardiovascular events, DKA, and AKI than no SGLT2i use in patients with T2D and stage 5 CKD. ✅https://www.acpjournals.org/doi/10.7326/M23-1874?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed #MedX #MedTwitter #CardioTwitter #medx #medEd #MedTwitter #MedEd #cardiotwitter #FOAMed #CardioEd #Cardiology #MedEd #ENARM #cardiotwiteros #meded #cardiology #CardioTwitter #CardioEd #medtwitterWhat
Show all...
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease | Annals of Internal Medicine

Background: No studies have reported the long-term outcomes of initiating sodium–glucose cotransporter-2 inhibitors (SGLT2is) in patients with estimated glomerular filtration rates less than 20 mL/min/1.73 m2 to predialysis. Objective: To compare the risk for dialysis, cardiovascular events, and death between SGLT2i users and nonusers in patients with type 2 diabetes (T2D) and stage 5 chronic kidney disease (CKD). Design: Target trial emulation study. Setting: Taiwan’s National Health Insurance Research Database (NHIRD). Participants: By applying sequential target trial emulation principle, 23 854 SGLT2i users and 23 892 SGLT2i nonusers were selected from the NHIRD for patients with T2D and stage 5 CKD from 1 May 2016 to 31 October 2021. Measurements: Conditional Cox proportional hazards models were used to compare the risks for dialysis, hospitalization for heart failure, acute myocardial infarction (AMI), diabetic ketoacidosis (DKA), acute kidney injury (AKI), and all-cause mortality between SGLT2i users and…

2
BEDTIME VERSUS MORNING يتحدث مصدر UpToDate عن الوقت المناسب لاستخدام ادوية ارتفاع ضغط الدم 👇 DOSING: The contributors to this topic take different approaches to the timing of antihypertensive therapy: 1⃣One author and both section editors typically prescribe once-daily medications in the morning rather than the evening. This approach is supported by the European Society of Hypertension (ESH). 2⃣The other author prescribes once-daily drugs in the evening (between 6 and 8 PM [between 18:00 and 20:00]), except for diuretic medications (which are prescribed in the morning), unless the patient has glaucoma. Patients with glaucoma, particularly open-angle glaucoma, should not be prescribed antihypertensive medicines at night.
Show all...
9🔥 1
20
تريد معلومات طبية جديدة ومعتمدة 🔰 تريد مصادر طبية 📚 تريد شروحات 🎙 أدوية 💊 تطبيقات طبية . 🧠القناة الطبية الأولى على مستوى العراق قناة يبحث عنها كل طلاب المجموعة الطبية 🥼🩺 @Scientificpharmacists
Show all...
7👍 3👏 1
3👍 1